Stem cells versus senescence: the yin and yang of cardiac health.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.European journal of heart failure · 2016
   Trial
2. Overexpression of GREM1 Improves the Survival Capacity of Aged Cardiac Mesenchymal Progenitor Cells via Upregulation of the ERK/NRF2-Associated Antioxidant Signal Pathway.Cells · 2023
   Article
3. Metabolic Changes in Cardiac Aging.Reviews in cardiovascular medicine · 2023
   Review
4. Longevity leap: mind the healthspan gap.NPJ Regenerative medicine · 2021
   Review
5. "Empowering" Cardiac Cells via Stem Cell Derived Mitochondrial Transplantation- Does Age Matter?International journal of molecular sciences · 2021
   Review
6. Current Progress in the Rejuvenation of Aging Stem/Progenitor Cells for Improving the Therapeutic Effectiveness of Myocardial Repair.Stem cells international · 2018
   Review
7. Stem cell therapy for heart failure: Ensuring regenerative proficiency.Trends in cardiovascular medicine · 2016
   Review
8. Regenerative Medicine Build-Out.Stem cells translational medicine · 2015
   Review
9. Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy.Journal of the American Heart Association · 2015
   Article

Corrections and comments

• Comment on
  Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.2015
• Comment on
  Nucleostemin rejuvenates cardiac progenitor cells and antagonizes myocardial aging.2015

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as